Fulcrum Therapeutics (FULC) Current Deferred Revenue (2019 - 2023)
Fulcrum Therapeutics (FULC) reported Current Deferred Revenue of $334,000 for Q3 2023, down 76.0% from $1.39 million a year earlier and down 34.9% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Current Deferred Revenue (2019 - 2023) Analysis & Trends
At the end of FY2022, Fulcrum Therapeutics posted Current Deferred Revenue of $934,000, down 80.2% from FY2021.
- Current Deferred Revenue has a three-year compound annual growth rate of -38.4% (FY2019 to FY2022).
- By year, Current Deferred Revenue came in at $4.71 million in FY2021 (-68.4%), $14.91 million in FY2020 (+273.8%) and $3.99 million in FY2019.
- The Q3 2023 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2019.
- Year over year, Current Deferred Revenue has now declined in each of the last nine quarters, with an average decline of 75.7% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2020 (growth of 273.8%); the low point was Q2 2022 (a decline of 82.0%).
- Per Business Quant data, the three quarters before Q3 2023 came in at $513,000 (Q2 2023), $737,000 (Q1 2023) and $934,000 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Fulcrum Therapeutics | 282.26 Mn | 282.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 334,000.00 |
| Jun 30, 2023 | 513,000.00 |
| Mar 31, 2023 | 737,000.00 |
| Dec 31, 2022 | 934,000.00 |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 4.71 Mn |
| Sep 30, 2021 | 6.13 Mn |
| Jun 30, 2021 | 9.90 Mn |
| Mar 31, 2021 | 12.13 Mn |
| Dec 31, 2020 | 14.91 Mn |
| Sep 30, 2020 | 13.61 Mn |
| Jun 30, 2020 | 4.46 Mn |
| Mar 31, 2020 | 4.56 Mn |
| Dec 31, 2019 | 3.99 Mn |
API Access
Fulcrum Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();